YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Selective Cytotoxicity of Pt (II) Complex Containing 1,2-Bis (diphenylphosphino)ethane on Human Gastric Cancer Cell-Lines and Normal Kidney Cells

1,2-비스 (디페닐포스피노)에탄을 배위자로 한 항암성백금 (II) 착체의 위암세포와 정상신장세포에 대한 선택적 세포독성

  • Published : 2000.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

We have synthesized a novel platinum (II) coordination complex containing trans-ι-1,2-diaminocyclohexane (DACH) as a carrier ligand and 1,2-bis (diphenylphosphino)ethane (DPPE) as a leaving group. In addition, nitrate was added to improve the water-solubility. A new series of [Pt (trans-ι-DACH) (DPPE)].2NO$_3$(PC) was evaluated for its cytotoxic activity on MKN-45 human gastric adenocarcinoma cells and normal primary cultured kidney cells. PC has demonstrated high levels of cytotoxicity against MKN-45/S, MKN-45/ADR and MKN-45/CDDP cells. The cytotoxicity of PC against rabbit proximal renal tubular cells, human renal cortical cells, and human renal cortical tissues, determined using the MTT assaying technique, the ($^3$H)-thymidine uptake and the glucose consumption tests, was found to be quite less than those of cisplatin. Based on these results, this novel platinum (II) coordination complex appears to be better for improving antitumor activities with low nephrotoxicity and is a valuable lead in the development of new clinically available anticancer chemotherapeutic agents.

Keywords

References

  1. J.Biol.Cheml. v.242 no.1347 The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum complexes Rosenberg B.;Van Camp L.;Thomson A.J.
  2. Nature v.222 no.385 Platinum compounds : A new class of potent antitumor agents Rosenberg B.;Van Camp L.;Trosko J.E.;Monsour V.H.
  3. Biochimie v.60 no.399 Platinum complex-DNA interactions and anticancer activity Rosenberg B.
  4. J. Pharmacol. Exp. Ther. v.213 no.3 Mechanism of cisplatinum nephrotoxicity Dobyan D.C.;Levi I.;Jacobs C.
  5. Cancer Chemother.Rep. v.60 no.1678 Comparative nephrotoxicity of platinum cancer chemotherapeutic agent Ward J.M.;Young D.M.;Fauvie K.A.;Wolpert M.K.;Davis R.;Guarino A.M.
  6. Cancer Chemother.Rep. v.59 no.621 Review of the current clinical status of platinum coordination complexes in cancer chemotherapy Gottlieb J.A.;Drewinko B.
  7. Cancer Treat.Rep. v.63 no.1523 Nephrotoxicity of cis-diaminedichloro-platinum(II) Krakoff I.H.
  8. Ann .Clin.Lab.Sci. v.11 no.397 Methods of reduction of cisplatin nephrotoxicity Walker E.M.;Gale G.R.
  9. Cancer Res. v.37 no.455 Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia Burchenal J.H.;Kalaher K.;O'Toole T.;Chisholm J.
  10. Jap.J.Chem.Soc. v.4 no.684 Antitumor activity and mechanism of the platinum complexes Tashiro T.
  11. Chem.Biol.Interact v.5 no.415 New platinum complexes with antitumor activity Connors T.A.;Jones M.;Ross W.C.J.
  12. Yakugaku Zasshi v.105 no.909 Development of antitumor platinum complexes Kidani Y.
  13. Korean J.Pharmacol. v.32 no.93 in vitro antitumor activity and nephrotoxicity of the nevel platinum(II) coordination complex containing cis-DACH/diphosphine Jung J.C.;Chung J.H.;Chang S.G.;Rho Y.S.
  14. Anticancer Research v.15 no.675 New platinum complex compounds with reduced nephrotoxicity discovered in long-term histocultured of human renal cortical tissues Chang S.G.;Kwon D.U.;Kim J.I.;Jung J.C.;Rho Y.S.;Hoffman R.M.
  15. Nature v.182 no.1103 A rapid method for separating glomeruli from rabbit kidney Cook W.F.;Pickering G.W.
  16. J.Cellular Physiol. v.150 no.243 Growth and function of primary rabbit kidney proximal tubule cells in glucose-free serum-free medium Jung J.C.;Lee S.M.;Kadakia N.;Taub M.
  17. J.Immunol.Methods v.65 no.55 Rapid colorimetric assay for cellular growth and survival : application and cytotoxic assays Mossman T.
  18. In vitro Cell Dev.Biol v.28 no.A:128 Growth of human renal cortical tissues on collagen gel Chang S.G.;Toth K.;Black J.D.;Slocum H.K.;Perrapato S.D.;Huben R.P.;Rustum Y.M.
  19. In Vitro Cell Dev.Biol. v.28 no.A Glucose consumption end-point in primary histoculture indicates recovery of human tumors from drug treatment Chang S.G.;Slocum H.K.;Toth K.;Hoffman R.M.
  20. Anticancer Res. v.14 no.77 Comparison of glucose-consumption and thymidine-incorporation endpoints in histocultured human superficial bladder tumors Chang S.G.;Lee J.H.;Hong D.H.;Lee H.L.;Chai S.E.;Hoffman R.M.
  21. Biochem.Pharmacol. v.23 no.1345 Interactions between mammalian cell CNA interstrand crosslinking and cytotoxic properties of platinum(II) compounds Pascoe J.M.;Roberts J.J.
  22. Chem.Biol.Interact v.48 no.121 Exacerbation of cisplatin-induced nephrotoxicity by methionine Alden M.W.;Repta A.J.
  23. Clin.Pharmacol.Ther. v.27 no.557 Comparison of methods of evaluating nephrotoxicity of cis-platinum Brian R.;Ravi J.;Bhalla B.;Maldek J.
  24. Cancer v.39 no.1362 The renal pathology in clinical trials of cisplatinum Gonzales-Vitale J.C.;Hayes D.M.;Sternberg S.S.
  25. Clin.Pharmacol.Ther. v.27 no.4 Comparison of methods of evaluating nephrotoxicity of cis-platinum Jones B.R.;Bhalla R.B.;Madek J.
  26. Cancer Res. v.46 no.6 Selsctive protection against cis-diamminedichloro platinum(II) induced toxicity in kidney,gut and bone marrow by diethy-dithiocarbamate Bodenner D.L.;Dedon P.C.;Katz J.C.;Borch R.F.
  27. A report from the childrens group.Cancer v.73 no.1297 A Phase II study of carboplatin in children with recurrent or progressive solid tumors Ettinger L.T.;Gaynon P.S.;Krailo M.D.
  28. Proc.Natl.Acad.Sci. v.83 no.2684 In vivo-like growth of human tumors in vitro Freeman A.E.;Hoffman R.M.
  29. J.Cell.Biol. v.95 no.118 Characterization of primary rabbit kidney cultures that express proximal tubule functions in a hormonally defined medium Chung S.D.;Alavi N.;Livingston D.;Hiller S.;Taub M.
  30. Cancer Res. v.48 no.6017 Quiescent LLC-PK₁cells as a model for cis-diaminedichloro platinum(II) nephrotoxicity and modulation by thio rescue agents Mortine T.J.;Borch R.F.